Methamphetamine-Induced Dopamine Transporter Complex Formation and Dopaminergic Deficits: The Role of D2 Receptor Activation

Por Hadlock, Gregory C., Chu, Pei-Wen, Walters, Elliot T., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2010

Ex vivo identification of protein-protein interactions involving the dopamine transporter

Por Hadlock, Gregory C., Nelson, Chad C., Baucum, Anthony J., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2011

Methamphetamine Alters Vesicular Monoamine Transporter-2 Function and Potassium-Stimulated Dopamine Release

Por Chu, Pei-Wen, Hadlock, Gregory C., Vieira-Brock, Paula, Stout, Kristen, Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2010

Mechanisms Underlying Methamphetamine-Induced Dopamine Transporter Complex Formation

Por Hadlock, Gregory C., Baucum, Anthony J., King, Jill L., Horner, Kristen A., Cook, Glen A., Gibb, James W., Wilkins, Diana G., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2009

4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse

Por Hadlock, Gregory C., Webb, Katy M., McFadden, Lisa M., Chu, Pei Wen, Ellis, Jonathan D., Allen, Scott C., Andrenyak, David M., Vieira-Brock, Paula L., German, Christopher L., Conrad, Kevin M., Hoonakker, Amanda J., Gibb, James W., Wilkins, Diana G., Hanson, Glen R., Fleckenstein, Annette E.
Publicado em 2011